Dyne Therapeutics, Inc. (DYN) Capital expenditures 2019–2025
Dyne Therapeutics, Inc. (DYN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.9MFY2025 · since FY2019: $1.6M → $1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9M | -19.2% |
| FY2024 | $2.4M | +225.9% |
| FY2023 | $729,000 | -76.2% |
| FY2022 | $3.1M | -15.2% |
| FY2021 | $3.6M | +211.6% |
| FY2020 | $1.2M | -29.5% |
| FY2019 | $1.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice